Chapter: 1INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENTS
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

Chapter: 2EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

Chapter: 3MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.MARKET SHARE ANALYSIS, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS

3.4.1.MARKET DYNAMICS
3.4.2.Drivers
3.4.3.Restraints
3.4.4.Opportunities

Chapter: 4METHADONE MARKET, BY MODE OF ADMINISTRATION

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.ORAL MEDICINE

4.2.1.Key market trends
4.2.2.Growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Tablets
4.2.5.Liquid

4.3.INJECTIONS

4.3.1.Key market trends
4.3.2.Growth factors and opportunities
4.3.3.Market size and forecast

Chapter: 5METHADONE MARKET, BY APPLICATION

5.1.OVERVIEW

5.1.1.Market size and forecast

5.2.OPERATION

5.2.1.Market size and forecast

5.3.DETOXIFICATION

5.3.1.Market size and forecast

5.4.OTHERS

5.4.1.Market size and forecast

Chapter: 6METHADONE MARKET, BY GEOGRAPHY

6.1.OVERVIEW
6.2.NORTH AMERICA

6.2.1.Key market trends
6.2.2.Key growth factors and opportunities
6.2.3.Market size and forecast

6.2.3.1.U.S. market size and forecast
6.2.3.2.Canada market size and forecast
6.2.3.3.Mexico market size and forecast

6.2.4.North America Methadone Market by Mode of Administration
6.2.5.North America Methadone Market by Application 

6.3.EUROPE

6.3.1.Key market trends
6.3.2.Key growth factors and opportunities
6.3.3.Market size and forecast

6.3.3.1.Germany market size and forecast
6.3.3.2.France market size and forecast
6.3.3.3.UK market size and forecast
6.3.3.4.Italy market size and forecast
6.3.3.5.Spain market size and forecast
6.3.3.6.Rest of Europe market size and forecast

6.3.4.Europe Methadone Market by Mode of Administration
6.3.5.Europe Methadone Market by Application

6.4.ASIA-PACIFIC

6.4.1.Key market trends
6.4.2.Key growth factors and opportunities
6.4.3.Market size and forecast

6.4.3.1.Japan market size and forecast
6.4.3.2.China market size and forecast
6.4.3.3.Australia market size and forecast
6.4.3.4.India market size and forecast
6.4.3.5.South Korea market size and forecast
6.4.3.6.Taiwan market size and forecast
6.4.3.7.Rest of Asia-Pacific market size and forecast

6.4.4.Asia-Pacific Methadone Market by Mode of Administration
6.4.5.Asia-Pacific Methadone Market by Application

6.5.LAMEA

6.5.1.Key market trends
6.5.2.Key growth factors and opportunities
6.5.3.Market size and forecast

6.5.3.1.Brazil market size and forecast
6.5.3.2.Turkey market size and forecast
6.5.3.3.Saudi Arabia market size and forecast
6.5.3.4.South Africa market size and forecast
6.5.3.5.Rest of LAMEA market size and forecast

6.5.4.LAMEA Methadone Market by Mode of Administration
6.5.5.LAMEA Methadone Market by Application 

Chapter: 7COMPANY PROFILES

7.1.QINGHAI PHARM

7.1.1.Operating business segments
7.1.2.Business performance
7.1.3.Key strategic moves and developments

7.2.ROXANE (BOEHRINGER INGELHEIM)

7.2.1.Operating business segments
7.2.2.Business performance
7.2.3.Key strategic moves and developments

7.3.CENTRALPHARM

7.3.1.Operating business segments
7.3.2.Business performance
7.3.3.Key strategic moves and developments

7.4.MALLINCKRODT

7.4.1.Operating business segments
7.4.2.Business performance
7.4.3.Key strategic moves and developments

7.5.MACFARLAN SMITH

7.5.1.Operating business segments
7.5.2.Business performance
7.5.3.Key strategic moves and developments

7.6.VISTAPHARM

7.6.1.Operating business segments
7.6.2.Business performance
7.6.3.Key strategic moves and developments

7.7.DISKETS

7.7.1.Operating business segments
7.7.2.Business performance
7.7.3.Key strategic moves and developments

7.8.METHADOES

7.8.1.Operating business segments
7.8.2.Business performance
7.8.3.Key strategic moves and developments

7.9.AUROLIFE PHARMA LLC 

7.9.1.Operating business segments
7.9.2.Business performance
7.9.3.Key strategic moves and developments

7.10.DOLOPHINE

7.10.1.Operating business segments
7.10.2.Business performance
7.10.3.Key strategic moves and developments